The combination of
captopril (or other ACE inhibitors) and
procainamide possibly increases the risk of leucopenia, especially in patients with
renal impairment. No pharmacokinetic interaction occurs between
captopril and
procainamide.
It is recommended that white cell counts are monitored before concurrent use, every 2 weeks during the first 3 months of combined treatment, and then periodically thereafter.